|
04 Sep 2019 |
Janssen Announces U.S. FDA Breakthrough Therapy Designation for Investigational Prophylactic Vaccine for the Prevention of Respiratory Syncytial Virus in Older Adults
|
|
27 Aug 2019 |
Imcyse reports successful first-in-human Phase 1b study in type 1 diabetes with IMCY-0098
|
|
22 Aug 2019 |
Themis Bioscience Announces Exclusive License and Research Collaboration Agreement with MSD to Develop Vaccine Candidates
|
|
21 Aug 2019 |
Aimmune Enrolls First Patient in Phase 2 Trial of AR201 for Egg Allergy
|
|
20 Aug 2019 |
Tonix Pharmaceuticals Expands Preclinical Pipeline with Triple Reuptake Inhibitor, TNX-1600, for the Treatment of PTSD
|
|
20 Aug 2019 |
Vaxxilon Awarded CARB-X Grant to Advance Novel Prophylactic Vaccine to Prevent Klebsiella pneumoniae Infections
|
|
19 Aug 2019 |
ActoBio Therapeutics™ Receives IND Green Light for New Antigen-Specific Immunotherapy Study Aimed at Improving Celiac Patients' Tolerance of Gluten
|
|
19 Aug 2019 |
Inovio Completes Enrollment of its VGX-3100 Open-label Phase 2 Trial for Treatment of HPV-Related High-Grade Anal Dysplasia
|
|
14 Aug 2019 |
Gritstone Oncology Announces First Patient Dosed with SLATE, its “Off-The-Shelf” Neoantigen Immunotherapy
|
|
14 Aug 2019 |
Brain Cancer Patients Display Decreasing Tumor Biomarkers After Treatment with Novel Immunotherapy in AIVITA Biomedical's Phase 2 Clinical Trial
|
|
06 Aug 2019 |
Transfer from GSK and partnership with NIAID will enable Sabin to advance development of the candidate vaccines
|
|
05 Aug 2019 |
Lilly Announces Positive Results for Emgality® (galcanezumab-gnlm) from the CONQUER Study in Patients who Failed Previous Migraine Preventive Treatments
|
|
05 Aug 2019 |
SELLAS Announces Completion of Enrollment in Randomized Phase 2 VADIS Trial of Nelipepimut-S (NPS) in Women with Ductal Carcinoma In Situ (DCIS) of the Breast
|
|
31 Jul 2019 |
SELLAS Advances Galinpepimut-S (GPS) in Combination with KEYTRUDA® (pembrolizumab) Program with Dosing of First Patient in Phase 1/2 Basket Study
|
|
30 Jul 2019 |
New Startup Biotech Company Plans to Test Promising Herpes Vaccine for Both HSV-1 and HSV-2
|
|
29 Jul 2019 |
Inovio’s Cancer Immunotherapy (INO-5151) Targeting Prostate Cancer in Innovative Cancer Combination Trial
|
|
23 Jul 2019 |
ViiV Healthcare presents positive 96-week data from phase III study of investigational fostemsavir in heavily treatment-experienced patients with HIV at IAS 2019
|
|
17 Jul 2019 |
Elios Therapeutics Announces Positive Top-Line Data from Phase IIb Study Evaluating TLPLDC, a Personalized Therapeutic Cancer Vaccine, in Patients with High-Risk Melanoma
|
|
17 Jul 2019 |
Inovio Sharpens Focus On HPV-Related Diseases And Fast-to-Market Product Candidates
|
|
15 Jul 2019 |
New Immune Data from Ongoing ADXS-NEO Phase 1 Study Support Clinical Potential for Neoantigen-Directed Immunotherapies
|
|
15 Jul 2019 |
Neon Therapeutics’ Personal Neoantigen Vaccine Study Demonstrates Prolonged Progression-Free Survival in Advanced or Metastatic Melanoma, Non-Small Cell Lung and Bladder Cancers
|
|
12 Jul 2019 |
HOOKIPA Announces FDA Clearance of IND Application for HB-201 Clinical Trial to Treat HPV-Positive Cancers
|
|
11 Jul 2019 |
Transgene Receives MHRA Approval for Lead myvac™ Individualized Immunotherapy, TG4050, to Commence Clinical Development in HPV Negative Head and Neck Cancers in the UK
|
|
09 Jul 2019 |
Vaxart Enters into Research Collaboration with Janssen to Evaluate Oral Universal Influenza Vaccine
|
|
27 Jun 2019 |
Advaxis Announces Increasing Focus on Neoantigen-Directed Immunotherapies and Closing of Its Phase 3 AIM2CERV Study
|
